ASTONEA LABS LIMITED Share Price & Stock Analysis

ASTONEA LABS LIMITED (BSE: 544409) is a Panchkula, Haryana-based company in the Pharmaceuticals industry. With a market capitalisation of ₹373 Cr, it ranks #2,186 by market cap among the 6,197 Indian listed companies on FinBizNet, and #30 of 63 in Pharmaceuticals. At ₹350.00 (as of 16 Nov 2026), the share price is 5.1% below its 52-week high of ₹369.00 and 155.4% above its 52-week low of ₹137.05. The share price is up 118.9% over one year and up 25.9% over three months.

Key Metrics

Current Price₹350.00
Market Cap₹373 Cr
BSE Code544409
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio79.1
Return on Assets4.43%
52-Week Range₹137.05 – ₹369.00
1-Year Price Change+118.9%
3-Month Price Change+25.9%
Beta (1Y)0.12
HeadquartersPanchkula, Haryana
Websitewww.astonea.org/

Shareholding and Delivery

Delivery averaged 100.0% of traded volume across 5 BSE sessions (30 Oct 2026 – 13 Nov 2026).

About ASTONEA LABS LIMITED

Astonea Labs Limited manufactures and markets pharmaceutical and cosmetic products under the Glow Up, Avicel, and Regero brand names in India and internationally. The company offers pharmaceutical products, including generics, OTC products, specialty therapeutics, nutraceuticals, and biosimilars, as well as cosmetic and personal care products, such as skincare, haircare, anti-aging, ethical, and organic cosmetic lines. It offers its products in tablets, capsules, softgels, soaps, oral and external powders, ointments, aerosols, creams, and lotions, as well as toothpastes and mouthwashes. Astonea Labs Limited was incorporated in 2017 and is based in Panchkula, India.

Products and Services

1. Manufacture and Sale of Drugs & Cosmetics-This segment manufactures and markets pharmaceutical and cosmetic products. It offers antibiotic drugs, anti-cold medications, and antihistamines; and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, and fungal infections, as well as multivitamins. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Manufacture and Sale of Drugs & Cosmetics-100%

ASTONEA LABS LIMITED vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
ASTONEA LABS LIMITED₹373 Cr79.1——+118.9%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of ASTONEA LABS LIMITED?

ASTONEA LABS LIMITED is trading at ₹350.00, with a market capitalisation of ₹373 Cr.

Which sector does ASTONEA LABS LIMITED belong to?

ASTONEA LABS LIMITED operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of ASTONEA LABS LIMITED?

ASTONEA LABS LIMITED has a P/E of 79.1.

What is the stock symbol of ASTONEA LABS LIMITED?

ASTONEA LABS LIMITED is listed on the BSE under the scrip code 544409.

How has ASTONEA LABS LIMITED's share price moved over the past year?

ASTONEA LABS LIMITED's share price is up 118.9% over one year and up 25.9% over three months. Its 52-week range is ₹137.05 to ₹369.00.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.